Literature DB >> 19819646

[Primary actinomycosis of the breast due to Actinomyces neuii].

A Roustan1, M Al Nakib, L Boubli.   

Abstract

Primary actinomycosis of the breast is a rare disease, with only 32 cases reported in the literature since 1893. The diagnosis is done in front of a recurrent abscess with fistulas and purulent discharge. Bacteriologic analysis only can confirm the diagnosis. We report the first case of primary actinomycosis of the breast caused by Actinomyces neuii, in a 46-year-old premenopausal woman. No cause of this condition was reported. Targeted antibiotic therapy did not improve the condition. A tumorectomy of the breast was decided. Six months after surgery, no recurrence has been observed. Copyright 2009 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19819646     DOI: 10.1016/j.jgyn.2009.09.005

Source DB:  PubMed          Journal:  J Gynecol Obstet Biol Reprod (Paris)        ISSN: 0150-9918


  5 in total

Review 1.  Actinomyces neuii: review of an unusual infectious agent.

Authors:  Alexander von Graevenitz
Journal:  Infection       Date:  2011-02-22       Impact factor: 3.553

2.  Actinomyces Species Isolated from Breast Infections.

Authors:  A U Bing; S F Loh; T Morris; H Hughes; J M Dixon; K O Helgason
Journal:  J Clin Microbiol       Date:  2015-07-29       Impact factor: 5.948

3.  Primary Actinomycosis in the breast caused by Actinomyces neuii. A report of 2 cases.

Authors:  B S Leenstra; C C M Schaap; M Bessems; N H M Renders; K Bosscha
Journal:  IDCases       Date:  2017-04-01

4.  Actinomyces neuii: a case report of a rare cause of acute infective endocarditis and literature review.

Authors:  Wei-Teng Yang; Matthew Grant
Journal:  BMC Infect Dis       Date:  2019-06-10       Impact factor: 3.090

Review 5.  Infections Caused by Actinomyces neuii: A Case Series and Review of an Unusual Bacterium.

Authors:  Nathan Zelyas; Susan Gee; Barb Nilsson; Tracy Bennett; Robert Rennie
Journal:  Can J Infect Dis Med Microbiol       Date:  2016-02-29       Impact factor: 2.471

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.